USBC (USBC) clears resale of 367.6M shares amid Bitcoin-focused pivot
USBC, Inc. is registering up to 367.6 million shares of common stock for resale by existing stockholders, which will not generate proceeds for the company. These shares were primarily issued in connection with a 2025 private placement and preferred stock redemption, as USBC has shifted its focus from legacy sensor technologies to a blockchain-centric financial services model. The new strategy includes a Bitcoin treasury and a tokenized U.S. dollar deposit platform developed with Vast Bank and Uphold, but it introduces significant price, liquidity, regulatory, and counterparty risks.
Invesco Bond Fund stock (US92340E1091): Why Google Discover changes matter more now
The article discusses how Google's 2026 Discover Core Update is transforming how investors access information about Invesco Bond Fund stock (US92340E1091). It highlights Discover's new ability to push personalized fixed income insights directly to users' mobile feeds, optimizing for mobile-first content and E-E-A-T principles. This change enables faster decision-making for retail investors by providing timely data on metrics like duration, yield, and sector weightings without traditional searches.
Virtus Global Multi Sector Income Fund : April 20, 2026 - Virtus Closed-End Funds Joint Annual Meeting of Shareholders Proxy Statement
The proxy statement announces the Virtus Closed-End Funds Joint Annual Meeting of Shareholders to be held virtually on June 1, 2026, at 3:30 p.m. Eastern Time. Shareholders will vote on the election of trustees/directors for several Virtus funds and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm. The board unanimously recommends voting "FOR" all nominees and the ratification.
V2X to Announce First Quarter 2026 Financial Results
V2X, Inc. (NYSE: VVX) will report its first quarter 2026 financial results on Monday, May 4, 2026, after market close. Senior management will host a conference call at 4:30 p.m. ET on the same day, with details provided for both U.S. and international participants, as well as webcast and replay options. The company specializes in integrating physical and digital environments to enhance readiness and security across national security, defense, civilian, and international markets.
Thermon sees liquid load bank quotes surge on data center demand
Thermon Group Holdings Inc. reported a significant surge in liquid load bank solution quotes, reaching over $100 million as of April 2026, driven by high demand from the data center market. The company, which entered this market eight months ago, has already secured orders for approximately 80 units and sees a multi-year opportunity pipeline of $400 million, contributing to its robust organic growth and a 118% return for investors over the past year. This growth is also supplemented by recent news of a $2.2 billion merger agreement with CECO Environmental.
Tenet Healthcare (THC) Declines More Than Market: Some Information for Investors
Tenet Healthcare (THC) shares declined by 2.74% in the latest trading session, underperforming the S&P 500. The company is set to release its earnings report on April 30, 2026, with analysts expecting an EPS of $4.19 and revenue of $5.39 billion. THC currently holds a Zacks Rank #3 (Hold) and is trading at a Forward P/E ratio of 11.37, aligning with its industry average.
Enphase Energy Inc (ENPH) Stock Up 4.3% and Still Undervalued -- GF Score: 72/100
Enphase Energy Inc (ENPH) saw its stock rise by 4.3% to $33.88, despite being identified as "Significantly Undervalued" with a GF Value™ of $69.64, according to GuruFocus. The company's GF Score™ of 72/100 suggests above-average performance potential, driven by strong profitability and momentum. However, a growth rank of 4/10 and insider selling of $6.0 million against $0.3 million in purchases over the past three months raise concerns for potential investors.
Robbins LLP Encourages SLNO Stockholders to Contact the Firm for Information About the Class Action
Robbins LLP is encouraging stockholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO) to contact the firm regarding a class action lawsuit. The lawsuit alleges that Soleno Therapeutics misled investors about the safety and efficacy of its drug, DCCR, for Prader-Willi syndrome, citing concerns about fluid retention and adverse events. The complaint details stock declines following reports of an exposé on clinical trial issues, a patient death, and reduced DCCR launch trajectory due to community concerns.
Jefferies reiterates Caterpillar stock Buy rating on gas pipeline demand
Jefferies has reiterated a Buy rating and a $900.00 price target for Caterpillar Inc. (NYSE:CAT), driven by the anticipated multi-year expansion of U.S. natural gas pipeline capacity. This expansion is expected to generate an additional $0.7 billion to $1.5 billion in revenue for Caterpillar, a factor not fully reflected in current consensus estimates. The firm also maintained Caterpillar as its top machinery pick for 2026, noting undervalued cyclical growth opportunities beyond data center-related power generation.
Which AI Stock Is the Best Buy Today: Nvidia, Alphabet, or Palantir?
This article analyzes three major AI stocks: Nvidia, Alphabet, and Palantir, to determine the best investment. While Nvidia and Palantir show impressive growth in hardware and software respectively, their valuations are high, posing risks. Alphabet is presented as the top choice due to its diversified business model, accelerating Google Cloud segment, and more attractive valuation despite significant capital expenditure plans.





